Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women

International Journal of STD and AIDS

Volumn 19, Issue 1, 2008, Pages 37-41

  Lehtovirta, Päivi ^a   Paavonen, Jorma ^a   Heikinheimo, Oskari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

CIN; HIV; Risk factor

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER RISK; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX CARCINOMA IN SITU; HOSPITALIZATION; IMMUNOLOGY; INCIDENCE; LONGITUDINAL STUDY; PARITY; PREGNANCY; RECURRENT DISEASE; RISK FACTOR; UTERINE CERVIX TUMOR; VAGINA SMEAR; VAGINITIS; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; PARITY; PREGNANCY; PROGNOSIS; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VAGINOSIS, BACTERIAL; VIRAL LOAD;

EID: 42949152446     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2007.005672     Document Type: Article

References (35)

1. Serraino D, Carrieri P, Pradier C, et al. Risk of invasive cervix cancer among women with, or at risk for, HIV-infection. Int J Cancer 1999;82:334-7
2. Hawes S, Critchlow C, Mame A, et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 2003;188:555-63
3. Wright Jr TC, Ellerbrock TV, Chiasson MA, et al. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors and validity of Papanicolaou smears. Obstet Gynecol 1994;84:591-7
4. Maiman M, Fruchter RG, Sedlis A, et al. Prevalence, risk factors, accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol 1998;68:233-9
5. Heard I, Tassie J-M, Schmitz V, Mandelbrot L, Kazatchkine M, Orth G. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load. Obstet Gynecol 2000;96:403-9
6. Cardillo M, Hagan R, Abadi J, Abadi M. CD4 T-cell count, viral load, and squamous intraepithelial lesions in women infected with the human immunodeficiency virus. Cancer 2001;93:111-4
7. Davis A, Chakraborty L, Flowers L, Mosunjac M. Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): a correlation with HIV viral load and CD4+ count. Gynecol Oncol 2001;80:350-54
8. Palella FJ, Felaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60
9. Hammer SM. Clinical practise. Management of newly diagnosed HIV infection. N Engl J Med 2005;353:1702-10
10. Lillo F, Ferrari D, Veglia F, et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001;184:547-51
11. Minkoff H, Ahdieh L, Massad LS, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001;15:2157-64
12. Palefsky. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 2003;15:382-8
13. Kaplan JE, Masur H, Holmes KK; for the Infectious Diseases Society of America. Guidelines for preventing opportunistic infections among HIV-infected persons-2002: recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002;51:1-52
14. Harris TG, Burk RD, Palefsky JM, et al. Incidence of cervical squamous intraepithelial lesions associated with HIV serostaus, CD4 cell counts and human papilloma virus test results. JAMA 2005;293:1471-6
15. Lehtovirta P, Finne P, Nieminen P, et al. Prevalence and risk factors of squamous intraepithelial lesions of cervix among HIV-infected women - a long-term follow-up study in a low prevalence population. Int J STD AIDS 2006;17:831-4
16. Branca M, Rossi M, Alderisio G, et al. Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women. Cytopathology 2001;12:84-93
17. Anderson J, Paramsothy P, Heilig C, et al. Accuracy of Papanicolaou test among HIV-infected women. Clin Infect Dis 2006;42:562-8
18. Robinson W, Luck M, Kendall M, Darragh T. The predictive value of cytologic testing in women with the human immunodeficiency virus who have low-grade squamous cervical lesions: a substudy of randomized, phase III chemoprevention trial. Am J Obstet Gynecol 2003;188:896-900
19. Nieminen P, Vuorna S, Viikki M, Hakama M, Anttila A. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. Br J Obstet Gynaecol 2004;111:842-8
20. Massad LS, Riester KA, Anastos KM, et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acqiur Immune Defic Syndr 1999;21:33-41
21. Chirenje ZM, Loeb L, Mwale M, Nyamapfeni P, Kamba M, Padian N. Association of cervical SIL and HIV-1 infection among Zimbabwean women in an HIV/STI prevention study. Int J STD AIDS 2002;13:765-8
22. Heard I, Costagliola D, Orth G, Kazachkine D. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998;12:1459-64
23. Orlando G, Fasolo MM, Schiavini M, et al. Role of highly active antiretroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1-infected patients. AIDS 1999;13:424-5
24. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9
25. Bosch FX, Lorincz A, Munoz N, Meijer C, Shah K. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65
26. Mandelblatt JS, Kanetsky P, Eggert L, et al. Is HIV-infection a cofactor for cervical squamous cell neoplasia? Cancer Epidemiol Biomarkers Prev 1999;8:97-106
27. Perez-Gallego L, Moreno-Bueno G, Sarrio D, Suarez A, Gamallo C, Palacios J. Human papillomavirus-16 E6 variants in cervical squamous intraepithelial lesions from HIV-negative and HIV-positive women. Am J Clin Pathol 2001;116:143-8
28. Chaturvedi AK, Brinkman JA, Gaffga AM, et al. Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women. J Gen Virol 2004;85:1237-41
29. Heard I, Tassie J-M, Kazatchkine M, Orth G. Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS 2002;16:1799-802
30. Moore AL, Sabin CA, Madge S, et al. Highly active antiretroviral therapy and cervical intraepithelial neoplasia. AIDS 2002;16:927-9
31. Watts DH, Fazzari M, Minkoff H, et al. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis 2005;191:1129-39
32. Platz-Christiansen JJ, Sundström E, Larsson PG. Bacterial vaginosis and cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand 1994;73:586-8
33. Tebeu P, Major A, Mhawech P, Rapiti E. The recurrence of cervical intraepihelial neoplasia in HIV-positive women: a review of the literature. Int J STD AIDS 2006;17:507-11
34. Heard I, Potard V, Foulot H, Chapron C, Costagliola D, Kazatchkine M. High rate of recurrence of cervical intraepithelial neoplasia after surgery in HIV-positive women. J Acqiur Immune Defic Syndr 2005;39:412-8
35. Tate DR, Anderson RJ. Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: a case-control analysis. Am J Obstet Gynecol 2002;186:880-82